Search Results

Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients

• Authors : Mohanad Mousa Taha Odeh, Director of Pharmacy Management & Pharmaceutical Care Innovation Centrer

• Source: Intraoperative Insulin Administration (Infusion Regimen vs. Bolus Regimen) at Cardiac Surgery for Type II Diabetic Patients; A Randomised Control Trial.

Record details

Four-Week SkinSiteStudy in Type 1 Diabetes (SSS-4WK)

• Source: The Four-week Study of Skin Sites Used for Diabetes Devices in Children and Adolescents.

Record details

Prevention of Diabetes and Hypertension (PHIDIAS)

• Authors : Italian Society of Hypertension; Italian Society of General Practitioners; Yghea

• Source: Zanchetti A, Ruilope LM. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens. 2002

Record details

Health Dialogue Intervention Versus Opportunistic Screening for Type 2 Diabetes and Cardiovascular Disease Prevention

• Authors : Karolinska Institutet

• Source: Effectiveness of a Health Dialogue Intervention Versus Opportunistic Screening in Primary Care for Type 2 Diabetes and Cardiovascular Disease Prevention in Low Socioeconomic Settings - The DETECT

Record details

Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau (BCGTODM)

• Authors : University of Coimbra; Steno Diabetes Center Copenhagen; University of Southern Denmark

• Source: Correia JC, Lopes A, Iala CB, Sanca NA, Bidonga A, Lagger G, Golay A, Castellsague MP. Diabetes management in Guinea Bissau: a situational analysis. Pan Afr Med J. 2019 Sep 4;34:10. doi:

Record details

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation (Dapa-LiT)

• Authors : Dr Mohammad Shafi Kuchay, Senior Consultant

• Source: Ferrannini E, Seman L, Seewaldt-Becker E, Hantel S, Pinnetti S, Woerle HJ. A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes.

Record details

Reducing Cardiovascular Risk in Primary Care: a Randomized Clinical Trial (Misalud)

• Authors : National Fund for Research and Development in Health, Chile

• Source: Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K,

Record details

Physical Activity and Mortality in Type 2 Diabetes

• Authors : University of Aarhus; The Danish Diabetes Association; Jakob Tarp, Principal Investigator

• Source: Physical Activity and Mortality in Individuals With Type 2 Diabetes: Cross-country Comparison in UK Biobank and China Kadoorie Biobank

Record details

Aronia in the Type 2 Diabetes Treatment Regimen

• Source: Aronia in the Type 2 Diabetes Treatment Regimen

Record details

Establishment of the Human Intestinal and Salivary Microbiota Biobank- Diabetes (BIOMIS-Diab)

• Authors : Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; University Of Perugia; University of Bari Aldo Moro

• Source: Yu F, Han W, Zhan G, Li S, Jiang X, Wang L, Xiang S, Zhu B, Yang L, Luo A, Hua F, Yang C. Abnormal gut microbiota composition contributes to the development of type 2 diabetes

Record details